Russia reaches agreement with India on 100 million doses of anti-Convidian vaccine

The Russian Direct Investment Fund (RDIF) and India's pharmaceutical company Hetero have agreed to produce more than 100 million doses of Russia's Cavivar-19 vaccine, Sputnik V on Indian soil annually. Production expected to begin next year has said RDIF in a statement. This company had financed the development of the vaccine [...]
Production expected to begin next year has said RDIF in a statement. This company had financed the development of the Russian vaccine.
Her boss, Kiril Dmitriev, said the agreement “would offer the people of India an effective solution in this period of challenge from Pandemia”.
He added that the Sputnik V vaccine would become an integral “of each country's national vaccine portfolio portfolio”, Periscopi sent to RT.
This step was also appreciated by the Indian company. /Periscope











